Results 61 to 70 of about 11,372 (280)
The occurrence of multidrug-resistant Candida auris isolates and the increased mortality associated with invasive infections or outbreaks due to this Candida species have been reported in many healthcare settings.
Elena De Carolis+8 more
doaj +1 more source
Anidulafungin for Candida glabrata Infective Endocarditis [PDF]
Sir, we briefly report on a patient with infective endocarditis (IE) by Candida glabrata treated with double-dosage of anidulafungin.…
DE ROSA, Francesco Giuseppe+8 more
openaire +4 more sources
For calculated initial antifungal therapy, knowledge on parallel and cross-resistances are vitally important particularly in the case of multiresistant isolates.
Schmalreck, Arno F.+6 more
doaj +1 more source
The conundrum of antifungal resistance: Emergence of Nakaseomyces glabratus (Candida glabrata) in Europe with global implications. [PDF]
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 2, Page 255-256, February 2025.
Gupta AK, Wang T.
europepmc +2 more sources
Anidulafungin induced reversible thrombocytopenia in a patient: A case report
Anidulafungin is a semisynthetic antifungal agent which is an echinocandin. Here, we presented elderly patient developed reversible severe thrombocytopenia due to anidulafungin.
Zubeyir Cebeci+3 more
doaj +1 more source
Fungal infections can cause significant patient morbidity and mortality. Nanoparticle therapeutics have the potential to improve treatment of these infections.
Noel Vera-González+6 more
semanticscholar +1 more source
Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review [PDF]
The use of extracorporeal membrane oxygenation (ECMO) for reversible pulmonary failure in critically ill patients has increased over the last few decades.
Al-Shair+18 more
core +2 more sources
The seizure of illicit assets: patterns of civil forfeiture in Canada and Ireland [PDF]
No description ...
Gallant, M Michelle, King, Colin
core +1 more source
Echinocandins represent the newest class of antifungal agents. Currently, three echinocandins, anidulafungin, caspofungin and micafungin are licensed for clinical use in various indications.
Kofla G, Ruhnke M
doaj +1 more source
Flash pulmonary oedema during anidulafungin administration
Anidulafungin is an echinocandin antifungal used to treat invasive fungal infections caused by Candida or Aspergillus species. While the echinocandins are generally well tolerated, novel adverse reactions may occur. Specifically, echinocandins have been associated with histamine-mediated infusion reactions.
C. B. Hindahl, John Wilson
openalex +4 more sources